Cytodyn Inc (CYDY)

[MrGuru]

Ontscrewedme,

If you go by CYDY projections we have a range of $2.1 to $6 HIV Combo CONSERVATIVE range. If you want to make a "back of a napkin" calculation:

We get half of it from Vyera, we pay expenses internal of cytodyn (and maybe Vyera), research, salaries, royalties etc.

Let's say we really keep half of what we receive. So,

So revenue is $525M to $1.5B. If we use a multiplier of 4 for valuation (some use 3 and others use higher numbers such as 5 or 6). This is the difficult number to ascertain, apart, of course, from patients treated.

We have then: MC= $2.1B to $6B which translates to SP of $3 to $8.57 using the maximum authorized count share of 700 Million.

I have a much more detailed model (however don't have some inputs completely determined yet). In any case, it all depends on how many treatments we enlist. FYI, my model yields a SP range of $2.54 to $8.2.

Please bear in mind this is ONLY for Combinational therapy only.

Monotherapy and off-label usage is another ball game altogether.

And Oncology is another world …

This is one of the few Stock investments I feel great about enough to Pray for its success because first and foremost this may have saved the lives of multiple family members and currently a sibling battling Stage4MBC and countless others!

I feel the same. Sorry to hear about your sibling, I really hope CYDY or any other company can advance their research and commercialization rapidly and help her !!!